Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi India Ltd Regulatory Filings 2021

Apr 29, 2021

59270_rns_2021-04-29_169b08ef-93a1-42e3-9c68-032204381a67.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [88 x 71] intentionally omitted <==

29[th] April 2021

The Secretary The Secretary The National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, 5[th] Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G Block Dalal Street Bandra-Kurla Complex Mumbai 400 001 Bandra East Mumbai 400 050

Sub: Re-confirmation on non-applicability of SEBI Circular - SEBI/HO/DDHS/CIRIP/2018/144 dated November 26, 2018 with respect to fund raising by issuance of Debt Securities by Large entities

Dear Sirs

Pursuant to SEBI Circular - SEBI/HO IDDHS/CIR/P /2018/144 dated 26[th] November 2018 in respect of fund raising by issuance of debt securities by large entities, disclosures and compliances thereof by certain Large entities, we would like to re-confirm that Sanofi India Limited does not fall under the definition of ‘Large Corporate’ as per the applicability criteria in the aforesaid circular.

Request you to take the above information on record.

Thanking you,

Yours faithfully

For SANOFI INDIA LIMITED

==> picture [73 x 63] intentionally omitted <==

GIRISH TEKCHANDANI COMPANY SECRETARY

==> picture [452 x 13] intentionally omitted <==